{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:41:53Z","timestamp":1788918113827,"version":"build-2803163510"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Ubiquitin-specific protease 28 (USP28) is a deubiquitinating enzyme initially identified as a regulator that stabilizes p53 and c-MYC in response to DNA damage stress. Beyond its role in maintaining genomic integrity and cell cycle checkpoints, USP28 is implicated in diverse pathological processes. In various solid tumors, including lung, pancreatic, ovarian, and hepatocellular carcinomas, USP28 is markedly upregulated; it promotes proliferation, metabolic reprogramming, invasion, and therapeutic resistance by stabilizing oncoproteins such as c-Myc, STAT3, and SOX9. Conversely, in specific contexts like breast cancer and certain melanomas, USP28 deficiency drives malignant progression, revealing a context-dependent functional duality. These findings underscore the complexity of USP28 signaling and highlight its potential as a therapeutic target for precision medicine. This review summarizes the molecular characteristics and physiological functions of USP28, its context-dependent roles in neoplastic diseases, and its translational implications for targeted therapy and biomarker discovery.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1844555","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:38:44Z","timestamp":1784785124000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting the deubiquitinase USP28 in cancer: navigating context-dependent mechanisms and therapeutic resistance"],"prefix":"10.3389","volume":"17","author":[{"given":"Tongyong","family":"Luo","sequence":"first","affiliation":[{"name":"Pediatric Cardiology Center, Sichuan Provincial Women\u2019s and Children\u2019s Hospital\/The Affiliated Women\u2019s and Children\u2019s Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuncai","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, West China Hospital Sichuan University Jintang Hospital, Jintang First People\u2019s Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Hospital Sichuan University Jintang Hospital, Jintang First People\u2019s Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, West China Hospital Sichuan University Jintang Hospital, Jintang First People\u2019s Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Surgery, West China Hospital Sichuan University Jintang Hospital, Jintang First People\u2019s Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, West China Hospital Sichuan University Jintang Hospital, Jintang First People\u2019s Hospital","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Wang","sequence":"additional","affiliation":[{"name":"Pediatric Cardiology Center, Sichuan Provincial Women\u2019s and Children\u2019s Hospital\/The Affiliated Women\u2019s and Children\u2019s Hospital of Chengdu Medical College","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1042\/EBC20253026","article-title":"Small-molecule degron mimetics for targeted protein degradation","volume":"69","author":"Liu","year":"2025","journal-title":"Essays Biochem"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151798","article-title":"The essential role of E3 ubiquitin ligases in the pathogenesis of neurodevelopmental and psychiatric disorders: Cul3, Cul4, Ube3a, and ZNRF1","volume":"763","author":"Ohno","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.713322","article-title":"USP47-mediated deubiquitination and stabilization of TCEA3 attenuates pyroptosis and apoptosis of colorectal cancer cells induced by chemotherapeutic doxorubicin","volume":"12","author":"Hou","year":"2021","journal-title":"Front Pharmacol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41420-023-01629-1","article-title":"USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13051082","article-title":"The emerging role and mechanism of E2\/E3 hybrid enzyme UBE2O in human diseases","volume":"13","author":"Cheng","year":"2025","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.117872","article-title":"Therapeutic targeting of ubiquitin-specific protease 7 (USP7): mechanistic insights, dysregulation, and advances in drug discovery","volume":"296","author":"El-Hamaky","year":"2025","journal-title":"Eur J Med Chem"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1716673115","article-title":"K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains","volume":"115","author":"Ohtake","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.09.014","article-title":"The K48-K63 branched ubiquitin chain regulates NF-\u03baB signaling","volume":"64","author":"Ohtake","year":"2016","journal-title":"Mol Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13160","DOI":"10.1038\/s41598-022-16965-y","article-title":"The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis","volume":"12","author":"Vaughan","year":"2022","journal-title":"Sci Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14274","article-title":"Ufd2p synthesizes branched ubiquitin chains to promote the degradation of substrates modified with atypical chains","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2018.1549229","article-title":"A patent review of the ubiquitin ligase system: 2015-2018","volume":"28","author":"Li","year":"2018","journal-title":"Expert Opin Ther Pat"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2025.07.009","article-title":"E3 ubiquitin ligases in signaling, disease, and therapeutics","volume":"50","author":"Ebadi","year":"2025","journal-title":"Trends Biochem Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40164-023-00389-z","article-title":"Ubiquitin-specific protease 28: the decipherment of its dual roles in cancer development","volume":"12","author":"Ren","year":"2023","journal-title":"Exp Hematol Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s44319-024-00167-w","article-title":"Structural basis for the bi-specificity of USP25 and USP28 inhibitors","volume":"25","author":"Patzke","year":"2024","journal-title":"EMBO Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.molcel.2019.02.030","article-title":"Distinct USP25 and USP28 oligomerization states regulate deubiquitinating activity","volume":"74","author":"Gersch","year":"2019","journal-title":"Mol Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.molcel.2019.02.029","article-title":"Differential oligomerization of the deubiquitinases USP25 and USP28 regulates their activities","volume":"74","author":"Sauer","year":"2019","journal-title":"Mol Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae004","article-title":"The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage","volume":"52","author":"Jin","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10310","DOI":"10.1038\/s41467-025-66341-3","article-title":"Cancer-associated USP28 missense mutations disrupt 53BP1 interaction and p53 stabilization","volume":"16","author":"Belal","year":"2025","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112990","article-title":"The E3 ubiquitin ligase DTX3L and the deubiquitinase USP28 fine-tune DNA repair through mutual regulation of their protein levels","volume":"28","author":"Mennerich","year":"2025","journal-title":"iScience"},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12935-018-0722-9","article-title":"SENP1-mediated deSUMOylation of USP28 regulated HIF-1\u03b1 accumulation and activation during hypoxia response","volume":"19","author":"Du","year":"2019","journal-title":"Cancer Cell Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41418-025-01565-w","article-title":"A novel feedback loop between DYRK2 and USP28 regulates cancer homeostasis and DNA damage signaling","volume":"33","author":"Suanes-Cobos","year":"2026","journal-title":"Cell Death Differ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.chembiol.2025.08.002","article-title":"Pharmacologic interrogation of USP28 cellular function in p53 signaling","volume":"32","author":"Bratt","year":"2025","journal-title":"Cell Chem Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-1726","article-title":"Usp28 counteracts Fbw7 in intestinal homeostasis and cancer","volume":"75","author":"Diefenbacher","year":"2015","journal-title":"Cancer Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI73733","article-title":"The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer","volume":"124","author":"Diefenbacher","year":"2014","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41419-025-07647-4","article-title":"USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer","volume":"16","author":"Han","year":"2025","journal-title":"Cell Death Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-023-01173-6","article-title":"USP28 controls SREBP2 and the mevalonate pathway to drive tumour growth in squamous cancer","volume":"30","author":"Maier","year":"2023","journal-title":"Cell Death Differ"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.71596","article-title":"USP28 deletion and small-molecule inhibition destabilizes c-MYC and elicits regression of squamous cell lung carcinoma","volume":"10","author":"Ruiz","year":"2021","journal-title":"Elife"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201911101","article-title":"Maintaining protein stability of \u0394Np63 via USP28 is required by squamous cancer cells","volume":"12","author":"Prieto-Garcia","year":"2020","journal-title":"EMBO Mol Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01934-0","article-title":"Treatment of ovarian cancer beyond PARP inhibition: current and future options","volume":"83","author":"Garg","year":"2023","journal-title":"Drugs"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116315","article-title":"Investigation of the mechanism of USP28-mediated IFITM3 elevation in BCR-ABL-dependent imatinib resistance in CML","volume":"173","author":"Li","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-4129","article-title":"AKTing on R loops makes for an ATRactive target in ovarian cancer therapy","volume":"84","author":"Ramanarayanan","year":"2024","journal-title":"Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1038\/s41467-024-48667-6","article-title":"Histopathologic image-based deep learning classifier for predicting platinum-based treatment responses in high-grade serous ovarian cancer","volume":"15","author":"Ahn","year":"2024","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/jcmm.12426","article-title":"Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth","volume":"19","author":"Zhang","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1401949","article-title":"USP28 protects development of inflammation in mouse intestine by regulating STAT5 phosphorylation and IL22 production in T lymphocytes","volume":"15","author":"Le Menn","year":"2024","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5c01889","article-title":"USP28-based deubiquitinase-targeting chimeras for cancer treatment","volume":"147","author":"Wang","year":"2025","journal-title":"J Am Chem Soc"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7150\/thno.99340","article-title":"Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21","volume":"14","author":"Han","year":"2024","journal-title":"Theranostics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-17-0452","article-title":"USP28 deficiency promotes breast and liver carcinogenesis as well as tumor angiogenesis in a HIF-independent manner","volume":"16","author":"Richter","year":"2018","journal-title":"Mol Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5c01662","article-title":"Harnessing the deubiquitinase USP1 for targeted protein stabilization","volume":"147","author":"Qian","year":"2025","journal-title":"J Am Chem Soc"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.2c04824","article-title":"TF-DUBTACs stabilize tumor suppressor transcription factors","volume":"144","author":"Liu","year":"2022","journal-title":"J Am Chem Soc"},{"key":"B41","first-page":"LB367","article-title":"Abstract LB367: CT1113, a dual USP25\/28 inhibitor, promotes antitumor immunity by preventing YTHDF2-mediated complement activation and potentiates anti-PD-1 therapy","volume-title":"Cancer Res","author":"Zhou","year":"2025"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114558","article-title":"USP28 knockdown and small molecule inhibitors promote KRT1 destabilization and sensitize hepatocellular carcinoma cells to sorafenib","volume":"448","author":"Li","year":"2025","journal-title":"Exp Cell Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12193","article-title":"MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting ubiquitin-specific peptidase 28 expression","volume":"36","author":"Zhang","year":"2020","journal-title":"Kaohsiung J Med Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15509","article-title":"Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma","volume":"113","author":"Sun","year":"2022","journal-title":"Cancer Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.70095","article-title":"USP28 promotes osimertinib resistance in H1975 NSCLC cells by deubiquitinating and stabilizing SIRT1","volume":"42","author":"Fan","year":"2026","journal-title":"Kaohsiung J Med Sci"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123483","article-title":"USP28-mediated deubiquitination of FOXK1 activates the Hippo signaling pathway to regulate cell proliferation and radiosensitivity in lung cancer","author":"Meng","year":"2025","journal-title":"Life Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-024-02008-6","article-title":"Deubiquitinating enzyme USP28 inhibitor AZ1 alone and in combination with cisplatin for the treatment of non-small cell lung cancer","volume":"29","author":"Song","year":"2024","journal-title":"Apoptosis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S194917","article-title":"Ubiquitin-specific peptidase 28 enhances STAT3 signaling and promotes cell growth in non-small-cell lung cancer","volume":"12","author":"Li","year":"2019","journal-title":"Onco Targets Ther"},{"key":"B49","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41419-021-04163-z","article-title":"USP28 facilitates pancreatic cancer progression through activation of Wnt\/\u03b2-catenin pathway via stabilising FOXM1","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-024-01002-z","article-title":"USP28 promotes tumor progression and glycolysis by stabilizing PKM2\/HIF1-\u03b1 in cholangiocarcinoma","volume":"47","author":"Qiao","year":"2024","journal-title":"Cell Oncol (Dordr)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41419-021-03940-0","article-title":"Operative ubiquitin-specific protease 22 deubiquitination confers a more invasive phenotype to cholangiocarcinoma","volume":"12","author":"Tian","year":"2021","journal-title":"Cell Death Dis"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27305","article-title":"Knockdown of USP28 enhances the radiosensitivity of esophageal cancer cells via the c-Myc\/hypoxia-inducible factor-1 alpha pathway","volume":"120","author":"Weili","year":"2019","journal-title":"J Cell Biochem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2020_5504","article-title":"USP28 promotes aerobic glycolysis of colorectal cancer by increasing stability of FOXC1","volume":"68","author":"Liu","year":"2021","journal-title":"Acta Biochim Pol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2022.11.055","article-title":"Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer","volume":"638","author":"Shen","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28040","article-title":"USP28 contributes to the proliferation and metastasis of gastric cancer","volume":"120","author":"Zhao","year":"2019","journal-title":"J Cell Biochem"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152774","article-title":"The concomitant use of USP28 and p53 to predict the progression of urothelial carcinoma of the bladder","volume":"216","author":"Devrim","year":"2020","journal-title":"Pathol Res Pract"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104856","article-title":"The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells","volume":"299","author":"Li","year":"2023","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171960","article-title":"Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies","volume":"215","author":"Saei","year":"2018","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101443","article-title":"The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells","volume":"298","author":"Wang","year":"2022","journal-title":"J Biol Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02632-4","article-title":"NOTCH1 signaling is dysregulated by loss of the deubiquitinase USP28 with del(11q), uncovering USP28 inhibition as novel therapeutic target in CLL","volume":"39","author":"Ehrmann","year":"2025","journal-title":"Leukemia"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-84996-429-6_9","article-title":"Recent therapeutics in hepatocellular carcinoma","volume":"13","author":"Fan","year":"2023","journal-title":"Am J Cancer Res"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014798.pub2","article-title":"Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease","volume":"5","author":"Nadarevic","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02641-6","article-title":"HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098212","article-title":"The long run towards personalized therapy in non-small-cell lung cancer: current state and future directions","volume":"24","author":"Genova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15188","article-title":"TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma","volume":"8","author":"Han","year":"2017","journal-title":"Oncotarget"},{"key":"B66","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41419-017-0208-z","article-title":"Targeting deubiquitinase USP28 for cancer therapy","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332815","article-title":"Stomach microbiota in gastric cancer development and clinical implications","volume":"73","author":"Zeng","year":"2024","journal-title":"Gut"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5594973","article-title":"Upregulated tripartite motif 47 could facilitate glioma cell proliferation and metastasis as a tumorigenesis promoter","volume":"2021","author":"Ji","year":"2021","journal-title":"Comput Math Methods Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010030","article-title":"Multi-disciplinary care of hilar cholangiocarcinoma: Review of guidelines and recent advancements","volume":"16","author":"Padmanaban","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.767644","article-title":"Comprehensive analysis of the prognostic values of the TRIM family in hepatocellular carcinoma","volume":"11","author":"Dai","year":"2021","journal-title":"Front Oncol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13030768","article-title":"Prophylactic hyperthermic intraperitoneal chemotherapy for patients at high risk of developing gallbladder cancer peritoneal metastases: Case report and rationale for a prospective clinical trial","volume":"13","author":"Crum","year":"2024","journal-title":"J Clin Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.102164","article-title":"TRIM47 is a prognostic biomarker for gallbladder cancer and promotes tumor progression through regulating K63-linked ubiquitination of PARP1","volume":"51","author":"Xu","year":"2025","journal-title":"Transl Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12127","article-title":"BAALC-AS1\/G3BP2\/c-Myc feedback loop promotes cell proliferation in esophageal squamous cell carcinoma","volume":"41","author":"Zhang","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2020.06.01","article-title":"Precision screening for esophageal squamous cell carcinoma in China","volume":"32","author":"He","year":"2020","journal-title":"Chin J Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-020-0795-x","article-title":"RNA sequencing-based microRNA expression signature in esophageal squamous cell carcinoma: oncogenic targets by antitumor miR-143-5p and miR-143-3p regulation","volume":"65","author":"Wada","year":"2020","journal-title":"J Hum Genet"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3463","article-title":"Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis by sponging miR-206 to upregulate NETO2 and FOXP1 expression","volume":"9","author":"Zhang","year":"2020","journal-title":"Cancer Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2022.340038","article-title":"A multiplatform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma","volume":"1220","author":"Zhao","year":"2022","journal-title":"Anal Chim Acta"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.53795","article-title":"NETO2 promotes esophageal cancer progression by inducing proliferation and metastasis via PI3K\/AKT and ERK pathway","volume":"17","author":"Xu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic colorectal cancer: A review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/nu11010164","article-title":"Colorectal cancer and nutrition","volume":"11","author":"Thanikachalam","year":"2019","journal-title":"Nutrients"},{"key":"B83","doi-asserted-by":"publisher","first-page":"18353","DOI":"10.1038\/s41598-023-45164-6","article-title":"Hsa_circRNA_001676 accelerates the proliferation, migration and stemness in colorectal cancer through regulating miR-556-3p\/G3BP2 axis","volume":"13","author":"Hao","year":"2023","journal-title":"Sci Rep"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1186\/s12885-015-2018-y","article-title":"Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma","volume":"15","author":"Hu","year":"2015","journal-title":"BMC Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12863-017-0581-8","article-title":"Upregulation of NETO2 gene in colorectal cancer","volume":"18","author":"Fedorova","year":"2017","journal-title":"BMC Genet"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26844","article-title":"Advances in screening and detection of gastric cancer","volume":"125","author":"Xia","year":"2022","journal-title":"J Surg Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2020_200708N706","article-title":"Trim47 overexpression correlates with poor prognosis in gastric cancer","volume":"68","author":"Xia","year":"2021","journal-title":"Neoplasma"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.000000000002972","article-title":"Helicobacter pylori promotes YTHDF2-mediated SRA1 m6A modification and promotes the occurrence and development of gastric cancer","volume":"37","author":"Wang","year":"2025","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.55729\/2000-9666.1252","article-title":"Epidemiology of gastric cancer: Global trends, risk factors and premalignant conditions","volume":"13","author":"Grantham","year":"2023","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.55902","article-title":"Gastric cancer: A comprehensive literature review","volume":"16","author":"Mithany","year":"2024","journal-title":"Cureus"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8721654","article-title":"The diagnosis of early gastric cancer based on medical imaging technology and mathematical modeling","volume":"2022","author":"Xiu","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05319-7","article-title":"TAP1 promotes immune escape by activating JNK\/STAT1\/PD-L1 signaling in EBV-associated gastric cancer","volume":"480","author":"Shan","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B93","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1566524023666221221094432","article-title":"Epigenetic regulation in urothelial carcinoma","volume":"24","author":"Li","year":"2024","journal-title":"Curr Mol Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101843","article-title":"Treatment modalities for non-muscle invasive bladder cancer: An updated review","volume":"16","author":"McNall","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7150\/jca.123907","article-title":"Biomarkers for recurrence and prognosis in metastatic urothelial cancer: Emerging clinical applications","volume":"17","author":"Cendra","year":"2026","journal-title":"J Cancer"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2017.1312231","article-title":"Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma","volume":"18","author":"Pezzolo","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-022-02192-8","article-title":"DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression","volume":"93","author":"Chen","year":"2023","journal-title":"Pediatr Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21093319","article-title":"The potential functional roles of NME1 histidine kinase activity in neuroblastoma pathogenesis","volume":"21","author":"Adam","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000002908","article-title":"Burden trend and forecasting analysis of Malignant skin melanoma from 1990 to 2021","volume":"111","author":"Wang","year":"2025","journal-title":"Int J Surg"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155231","article-title":"Genetic biomarkers in melanoma of the ocular region: What the medical oncologist should know","volume":"21","author":"Bol","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13058-023-01672-x","article-title":"Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217\/G3BP2 signaling pathway","volume":"25","author":"Xia","year":"2023","journal-title":"Breast Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03793-w","article-title":"Deubiquitinase USP28 promotes the Malignant progression and radio-resistance of hepatocellular carcinoma by stabilizing WDHD1","volume":"398","author":"Wen","year":"2025","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2026.116221","article-title":"The ALKBH1\/MYC positive feedback loop regulates TAM polarization and remodels the tumor microenvironment to promote gastric cancer development","volume":"172","author":"Cui","year":"2026","journal-title":"Int Immunopharmacol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204869","article-title":"Comprehensive prognostic and immunological analysis of Ubiquitin Specific Peptidase 28 in pan-cancers and identification of its role in hepatocellular carcinoma cell lines","volume":"15","author":"Zhou","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/advs.75843","article-title":"IKK\u03b2 and USP28 regulate HEY1 stability to promote cancer stemness and immune evasion in hepatocellular carcinoma","volume":"26","author":"Shao","year":"2026","journal-title":"Adv Sci (Weinh)"},{"key":"B106","first-page":"CT142","article-title":"Abstract CT142: The first-in-human trial of USP28 inhibitor CT1113","volume-title":"Cancer Res","author":"Jin","year":"2025"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2026.112489","article-title":"The deubiquitinase USP28 promotes esophageal squamous cell carcinoma proliferation by stabilizing \u0394Np63 protein","volume":"143","author":"Cai","year":"2026","journal-title":"Cell Signal"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11020508","article-title":"Circulating biomarkers for prediction of immunotherapy response in NSCLC","volume":"11","author":"Goh","year":"2023","journal-title":"Biomedicines"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3390\/biom16040543","article-title":"A new era of salvage-line treatment for metastatic colorectal cancer: the role and clinical significance of circulating tumor DNA","volume":"16","author":"Toyokawa","year":"2026","journal-title":"Biomolecules"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2024.2408744","article-title":"Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma","volume":"24","author":"Fu","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2019.12.008","article-title":"Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors","volume":"10","author":"Liu","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c03045","article-title":"Structure merging approach leads to new dual potent and selective USP25\/USP28 inhibitors","volume":"69","author":"Hernandez-Olmos","year":"2026","journal-title":"J Med Chem"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.126459","article-title":"Prodrug strategy: molecular design for improving oral drug absorption","volume":"688","author":"Xiao","year":"2026","journal-title":"Int J Pharm"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1844555\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:38:45Z","timestamp":1784785125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1844555\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":113,"alternative-id":["10.3389\/fimmu.2026.1844555"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1844555","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1844555"}}